Authors: Burtness, B Windsor, S Holston, B DiStasio, S Staugaard-Hahn, C Abrantes, J Kneuper-Hall, R Farber, L Orell, J Bober-Sorcinelli, K Haffty, BG Reiss, M

Citation: B. Burtness et al., Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting, CA J SCI AM, 5(4), 1999, pp. 224-229